Anti-herpetic Properties of Hydroalcoholic Extracts and Pressed Juice from Echinacea pallida

Abstract

Hydroalcoholic extracts and pressed juice from Echinacea pallida were phytochemically characterised by HPLC‐MS analyses. Ferulic and caffeic acid derivatives were identified as major constituents. All tested extracts and pressed juice from Echinacea pallida exhibited a low cytotoxic activity on monkey kidney cells in vitro. The inhibitory activity of Echinacea against herpes simplex virus types 1 and 2 (HSV-1, HSV-2) was analysed with plaque reduction assays. All hydroalcoholic extracts exhibited high levels of antiviral activity against both types of herpesvirus in a dose-dependent manner. Plaque formation was significantly reduced by more than 99 % or completely absent. Pressed juice from E. pallida revealed the highest antiviral activity against HSV-1 and HSV-2 when compared to hydroalcoholic Echinacea extracts and even highly diluted Echinacea pressed juice still inhibited viral infectivity. Hydroalcoholic extracts were quite active against herpetic infection when HSV-1 or HSV-2 were pretreated with the extracts. In contrast, Echinacea pressed juice revealed antiviral activity during all phases of the viral replication cycle. Additionally, Echinacea pressed juice demonstrated protection of cells against viral infection. In conclusion, hydroalcoholic E. pallida extracts interfere with free herpesvirus but pressed juice is able to interact with herpesvirus inside and outside the cell as well as to protect cells against viral infection, probably by interfering with virus attachment. Hydroalcoholic extracts and pressed juice from E. pallida demonstrated high selectivity indices, a necessary prerequisite for a potential topical treatment of herpetic infections. Different types of Echinacea preparations, such as commercial tinctures, tablets, and teas, are expected to offer different antiviral profiles.

Key words

antiviral - herpes simplex virus - Echinacea pallida - Asteraceae - hydroalcoholic extract - Echinacea pressed juice

References

• 1 Chen Y, Scieux V, Garrait V, Socié G, Rocha V, Molina J M, Thouvenot D, Morfin F, Hocqueloux I, Garderei L, Esperou H, Selimi F, Dervergie A, Lelen G, Aymard M, Morinet F, Gluckman E, Ribaud P. Resistent herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.  Clin Infect Dis. 2000;  31 927-935
• 2 De Clercq E. Antiviral drugs in current clinical use.  J Clin Virol. 2004;  30 115-133
• 3 Bacon T H, Levin M J, Leary J J, Sarisky R T, Sutton D. Herpes simplex virus resistance to acyclovir and pencyclovir after two decades of antiviral therapy.  Clin Microbiol Rev. 2003;  16 114-128
• 4 Koytchev R, Alken R G, Dundarov S. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.  Phytomedicine. 1999;  6 225-230
• 5 Carson C F, Ashton L, Dry L, Smith D W, Riley T V. Melaleuca alternifolia (tea tree) oil gel (6 %) for the treatment of recurrent herpes labialis.  Antimicrob Agents Chemother. 2001;  48 450-451
• 6 Jassim S A, Naji M A. Novel antiviral agents: a medicinal plant perspective.  J Appl Microbiol. 2003;  95 412-427
• 7 Barrett B. Medicinal properties of Echinacea: a critical review.  Phytomedicine. 2003;  10 66-86
• 8 Woelkart K, Linde K, Bauer R. Echinacea for preventing and treating the common cold.  Planta Med. 2008;  74 633-637
• 9 Goel V, Lovlin R, Chang C, Slama J V, Barton R, Gahler R, Bauer R, Goonewardene L, Basu T K. A proprietary extract from the Echinacea plant (Echinacea purpurea) enhances systemic immune responses during a common cold.  Phytother Res. 2005;  19 689-694
• 10 Linde K, Barrett B, Woelkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold.  Cochrane Database Syst Rev. 2006;  (1) CD000530
• 11 Woelkart K, Bauer R. The role of alkamides as an active principle of Echinacea.  Planta Med. 2007;  73 615-623
• 12 Zwickey H, Brush J, Iacullo C M, Connelly E, Gregory W L, Soumyanath A, Buresh R. The effect of Echinacea purpurea, Astralagus membranaceus and Glycyrrhiza glabra on CD25 expression in humans: a pilot study.  Phytother Res. 2007;  21 1109-1112
• 13 Wacker A, Hilbig A. Virus inhibition by Echinacea purpurea.  Planta Med. 1978;  33 89-102
• 14 Thompson K D. Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus.  Antiviral Res. 1998;  39 55-61
• 15 Vimalanathan S, Kang L, Amiguet V T, Livesey J, Arnason J T, Hudson J. Echinacea purpurea aerial parts contain multiple antiviral compounds.  Pharm Biol. 2005;  43 740-745
• 16 Hudson J, Vimalananthan S, Kang I, Amiguet V T, Livesey J, Amason J T. Characterization of antiviral activities in Echinacea root preparations.  Pharm Biol. 2005;  43 790-796
• 17 Schnitzler P, Koch C, Reichling J. Susceptibility of drug-resistant clinical HSV-1 strains to essential oils of ginger, thyme, hyssop and sandalwood.  Antimicrob Agents Chemother. 2007;  51 1859-1862
• 18 Reichling J, Koch C, Stahl-Biskup E, Sojka C, Schnitzler P. Virucidal activity of a β-triketone-rich essential oil of Leptospermum scoparium (manuka oil) against HSV-1 and HSV-2 in cell culture.  Planta Med. 2005;  71 1123-1127
• 19 Bauer R, Remiger P, Wagner H. Echinacea – Vergleichende DC- und HPLC-Analyse der Herba-Drogen von Echinacea purpurea, E. pallida und E. angustifolia (3. Mitt.).  Dtsch Apotheker Ztg. 1988;  128 174-180
• 20 Woelkart K, Dittrich P, Beubler E, Pini F, Schoop R, Suter A, Bauer R. Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans.  Planta Med. 2008;  74 651-656
• 21 Woelkart K, Marth E, Suter A, Schoop R, Raggam R, Koidl C, Kleinhappl B, Bauer R. Bioavailability and pharmacokinetic studies on Echinacea purpurea preparations and their interaction with the immune system.  Int J Clin Pharm Ther. 2006;  44 401-408
• 22 Barnes J, Anderson L A, Gibbons S, Phillipson J D. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.  J Pharm Pharmacol. 2005;  57 929-954
• 23 Binns S E, Hudson J, Merali S, Arnason J T. Antiviral activity of characterized extracts from Echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-1).  Planta Med. 2002;  68 780-783
• 24 Bodinet C, Beuscher N. Antiviral and immunological activity of glycoproteins from Echinacea purpurea Radix.  Planta Med. 1991;  57 (Suppl. 2) A33